<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>易凯资本 | wechat-feeds</title><link>http://MzI4MjA1OTcyMg.favicon.privacyhide.com/favicon.ico</link><description>易凯资本新闻资讯发布官方平台</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 31 Mar 2021 11:27:46 +0800</pubDate><image><url>http://MzI4MjA1OTcyMg.favicon.privacyhide.com/favicon.ico</url><title>易凯资本 | wechat-feeds</title><link>http://MzI4MjA1OTcyMg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>易凯资本宣布晋升张骁为合伙人|易凯新闻</title><link>https://mp.weixin.qq.com/s/F21zwGCMv85_7MvAB7gCfg</link><description></description><content:encoded><![CDATA[易凯资本宣布晋升张骁为合伙人|易凯新闻]]></content:encoded><pubDate>Wed, 31 Mar 2021 10:11:40 +0800</pubDate></item><item><title>Immune-Onc Therapeutics完成约7300万美元B1/B2轮融资 易凯资本担任独家财务顾问</title><link>https://mp.weixin.qq.com/s/Wm1wIhflF-4AmC0Jo5JOwA</link><description></description><content:encoded><![CDATA[Immune-Onc Therapeutics完成约7300万美元B1/B2轮融资 易凯资本担任独家财务顾问]]></content:encoded><pubDate>Tue, 30 Mar 2021 20:00:31 +0800</pubDate></item><item><title>衡道病理完成B轮融资，易凯资本担任独家财务顾问</title><link>https://mp.weixin.qq.com/s/v6d-ewaw0e0Z6y3zY2azhA</link><description></description><content:encoded><![CDATA[衡道病理完成B轮融资，易凯资本担任独家财务顾问]]></content:encoded><pubDate>Mon, 29 Mar 2021 07:49:56 +0800</pubDate></item><item><title>上海细胞治疗集团完成D1轮近5亿元人民币融资，易凯资本担任独家财务顾问</title><link>https://mp.weixin.qq.com/s/2yXNKNuqd1egfv2SEWiG3A</link><description></description><content:encoded><![CDATA[上海细胞治疗集团完成D1轮近5亿元人民币融资，易凯资本担任独家财务顾问]]></content:encoded><pubDate>Wed, 24 Mar 2021 00:24:57 +0800</pubDate></item><item><title>极目生物完成超1亿美元B轮融资，易凯资本担任独家财务顾问</title><link>https://mp.weixin.qq.com/s/hbTsfwNtSBnLr86sPSN_-g</link><description></description><content:encoded><![CDATA[极目生物完成超1亿美元B轮融资，易凯资本担任独家财务顾问]]></content:encoded><pubDate>Wed, 10 Mar 2021 00:07:14 +0800</pubDate></item><item><title>澳斯康生物制药完成超4亿元人民币C轮融资，易凯资本担任独家财务顾问</title><link>https://mp.weixin.qq.com/s/fQ9YjN5EHrZPGWr5kr-6aQ</link><description></description><content:encoded><![CDATA[澳斯康生物制药完成超4亿元人民币C轮融资，易凯资本担任独家财务顾问]]></content:encoded><pubDate>Wed, 10 Mar 2021 00:07:14 +0800</pubDate></item><item><title>晟斯生物连续完成逾8亿元融资，易凯资本担任独家财务顾问</title><link>https://mp.weixin.qq.com/s/80ziEkJTp8RBDvZDq9ny-w</link><description></description><content:encoded><![CDATA[晟斯生物连续完成逾8亿元融资，易凯资本担任独家财务顾问]]></content:encoded><pubDate>Wed, 03 Mar 2021 22:55:40 +0800</pubDate></item><item><title>药明奥测完成1.5亿美元B轮融资，易凯资本担任独家财务顾问</title><link>https://mp.weixin.qq.com/s/fLKZBLeIQ601_hNy2W9UbQ</link><description></description><content:encoded><![CDATA[药明奥测完成1.5亿美元B轮融资，易凯资本担任独家财务顾问]]></content:encoded><pubDate>Wed, 24 Feb 2021 00:40:38 +0800</pubDate></item><item><title>依生生物完成1.3亿美元B轮融资，易凯资本担任独家财务顾问</title><link>https://mp.weixin.qq.com/s/Nds7rqX-vTYNUMyZ8wetBg</link><description></description><content:encoded><![CDATA[依生生物完成1.3亿美元B轮融资，易凯资本担任独家财务顾问]]></content:encoded><pubDate>Wed, 24 Feb 2021 00:40:38 +0800</pubDate></item><item><title>先通医药完成D轮融资，易凯资本担任独家财务顾问</title><link>https://mp.weixin.qq.com/s/lT29V5e14XK1FQqbseNO9w</link><description></description><content:encoded><![CDATA[先通医药完成D轮融资，易凯资本担任独家财务顾问]]></content:encoded><pubDate>Tue, 23 Feb 2021 00:26:17 +0800</pubDate></item><item><title>分享图片</title><link>https://mp.weixin.qq.com/s/8fn_8jRceMROjn2GtelyQg</link><description></description><content:encoded><![CDATA[分享图片]]></content:encoded><pubDate>Wed, 10 Feb 2021 23:37:32 +0800</pubDate></item><item><title>微远基因完成C轮2亿元人民币融资，易凯资本担任独家财务顾问</title><link>https://mp.weixin.qq.com/s/FeYFDp-lqxvqNbHvuURQLA</link><description></description><content:encoded><![CDATA[微远基因完成C轮2亿元人民币融资，易凯资本担任独家财务顾问]]></content:encoded><pubDate>Thu, 04 Feb 2021 00:15:52 +0800</pubDate></item></channel></rss>